Sell Vertex Pharmaceuticals (VRTX) stock to fund a goal
Calculator · free · no signup · VRTXNeed cash for a goal? Plan the minimum-tax schedule to sell your vested Vertex Pharmaceuticals (VRTX) shares and net a target amount by a target date, across tax years.
Beta · invite-only · AlphaLatitude Inc. · Free Tools
Inputs
Your equity
One stack per ticker (current-employer RSUs, prior-employer holdings, index fund, etc.). Each stack has its own current price, growth assumption, and cost-basis lots.
Drives chance-of-shortfall · default 30%
Lots
Plan
Estimates only. Not financial advice.
Lock-in-now is deterministic (0%). Plans that wait depend on future prices; risk is near-zero when inventory comfortably exceeds the goal. Volatility: each stack's option-implied vol if a ticker is set, otherwise 30%. Lognormal model; real markets have fatter tails.
| Tax | $109,597 | $111,639 | $111,883 | $118,769 |
| Wealth @ target | $719,068 | $716,894 | $714,464 | $712,031 |
| Chance of shortfall | <0.1% | 0% | 1.9% | 3.4% |
Feasible
$400,071 net by 08/01/27
Total tax: $109,597 (federal $58,819, state $36,048, NIIT $14,729)
Schedule · Recommended
| Sale date | Shares | Tax | Net | Cumulative |
|---|---|---|---|---|
| 08/17/26 | 4,085 | $351,104 | $360,043 | |
| 03/31/27 | 4 | $360 | $360,406 | |
| 04/30/27 | 32 | $2,896 | $363,321 | |
| 05/31/27 | 100 | $9,103 | $372,466 | |
| 06/30/27 | 100 | $9,157 | $381,644 | |
| 07/31/27 | 100 | $9,212 | $390,857 | |
| 08/01/27 | 100 | $9,215 | $400,071 |
Risk vs wealth
Each dot is a possible plan. Right is riskier, up is more wealth left over.
Trajectory of cash netted
Solid line = expected. Shaded band = 10th–90th percentile under price uncertainty.
After the plan
You keep 3,479 shares worth $411,873 at the projected target-date price, invested for the next decision.
You solved for a cash target. The beta optimizes your full portfolio across multiple goals and market scenarios, not just one funding need.
Request beta access →Related calculators: RSU Lot Order Calculator · Stock Concentration Calculator · RSU Sell-vs-Hold Calculator
About Vertex Pharmaceuticals
Vertex Pharmaceuticals (VRTX) is a public Other company, incorporated in Massachusetts and headquartered in Boston, MA.
Equity grants at Vertex Pharmaceuticals typically include restricted stock units (RSUs).
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.
Source: Wikipedia (CC BY-SA 4.0)
Joshua Boger founded the company in 1989 to design drugs from protein structure rather than screening. Cystic fibrosis became the franchise: Kalydeco, Orkambi, Symdeko, and Trikafta together treat the large majority of patients with the disease, a rare-disease monopoly with durable pricing. Casgevy, developed with CRISPR Therapeutics and approved in 2023 for sickle cell disease and beta thalassemia, was among the first CRISPR gene-editing therapies authorized anywhere. Pain and kidney disease programs aim to diversify. Headquarters are in Boston.
Sources: vrtx.com · en.wikipedia.org
Equity comp at Vertex Pharmaceuticals
- RSUs use single-trigger vesting: shares become yours as each portion vests on schedule, and the value is taxed as ordinary income at that point. No IPO or acquisition is required.
Researched 2026-08-17.
OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Vertex Pharmaceuticals.
If you hold vested Vertex Pharmaceuticals (VRTX) shares and need a set amount of cash by a date (a house down payment, tuition, a sabbatical, a business buy-in), the question is which lots to sell and in which tax years to keep the most after tax. This calculator builds the minimum-tax sell schedule across your lots, accounting for federal long-term capital gains, the net investment income tax, and your state.
All Vertex Pharmaceuticals tools → · Use the generic Stock Sale Funding Calculator for any company.
Vertex Pharmaceuticals equity questions
- How much VRTX stock do I sell to fund a goal without overpaying tax?
- It depends on your cost basis, your target amount and date, and how the sale spreads across tax years. Selling vested VRTX shares triggers long-term capital-gains tax, plus the 3.8% net investment income tax and state tax above certain income, and bunching a large sale into one year can push the gain into a higher bracket. The calculator above builds the minimum-tax sell schedule across your lots to net your target amount by your date.
- Does Vertex Pharmaceuticals grant ISOs, NSOs, or RSUs?
- Equity compensation at Vertex Pharmaceuticals typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
- Do Vertex Pharmaceuticals RSUs use double-trigger vesting?
- No. Vertex Pharmaceuticals restricted stock units (RSUs) use single-trigger vesting: each tranche becomes yours as it vests on schedule, taxed as ordinary income at that point, with no liquidity event required.
Find another companyOther peers
- RiverNorth Long Prime Unicorn Fund I, Inc.PublicOpen →
- RiverNorth Short Prime Unicorn Fund I, IncPublicOpen →
- Global X FundsPublicOpen →
- Accenture (ACN)PublicOpen →
- Cognizant (CTSH)PublicOpen →
- Globant (GLOB)PublicOpen →
- DXC Technology (DXC)PublicOpen →
- Eli Lilly (LLY)PublicOpen →
- Pfizer (PFE)PublicOpen →
- Merck (MRK)PublicOpen →
One piece of the puzzle.
OptionsAhoy plans your Vertex Pharmaceuticals equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.